Facial Angiofibroma |
Topical mTOR inhibitor
Only case studies or case series are available
Well tolerated; no systemic toxicity reported
Rapid response in weeks after initiating treatment
May be more efficacious for small, early lesions and for preventing recurrence after surgery
Clinical trial results pending
Laser surgery
Surgical excision
Should be considered for symptomatic, large lesions
May be considered for single or fewer fibrotic lesions
|
|
Cephalic Fibrous Plaque |
|
Sedation needed
Surgical risks
|
Skin Tags |
|
|
Hypo-pigmented Macules |
|
|
Ungual Fibroma |
Treatment is considered for incidental trauma
Topical mTOR inhibitor maybe considered for small lesions
Ablative laser or surgical excision may be considered if the lesions are symptomatic and larger than 3 mm in size
|
|
Intraoral Fibroma |
First line, good oral hygiene to minimize irritation
Consider electric cautery, ablative laser or surgical excision if obstructive
|
|
Dental Pits |
First line intervention, good dental hygiene
Restoration may be considered if at risk of dental caries
|
|
Jaw Cysts |
|
|